This week: a loophole keeps a dog out the Kansas governor’s race, a lion poacher gets poached by lions, and contaminated dog food sparks salmonella fears
This week: Cats! Two dead cats spark a cat food recall, a cat gets under a model’s skin—literally, and a cat owner adopts a kidney donor (it’s good to have a spare)
This week: rescue dogs on the catwalk, dog mats go upscale, and the Flintstones got it wrong about Dino
This week: Dogs get banned, a rescue backfires, and your pet wants to know if there’s anything good on Netflix.
This week: a Staffordshire terrier peers reviews papers, Colorado pays the tab for large animal vet students, and who gets the dog in a divorce?
Catch up on the latest pet and veterinary news from the last week. In this update: Congress introduces animal welfare bills, April the giraffe gives birth, researchers look at veterinarians' mental health, and the University of Missouri seeks dogs for clinical trials.
The opioid shortage is both a manufacturing issue and a manufactured one. The manufacturing part can be traced back to production issues at a Pfizer Inc. plant in Kansas and residual damage from last year’s Hurricane Maria in Puerto Rico, a major pharmaceutical manufacturing center. The manufactured part can be traced back to the US Drug Enforcement Agency.
This week: A daring baboon breakout, Congress could ban Americans from eating their pets, and a cancerous mass that’s anything but.
Catch up on the latest pet and veterinary news from the last week. In this update: Reporting animal abuse becomes mandatory in parts of Canada, a cloned dog gets cloned, and yes, dogs are smarter than cats.
The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.